|
|
M Ito, Y Mori, Y Oiso, H Saito
J Clin Invest. 1991;
87(2):725
doi:10.1172/JCI115052
Abstract |
Full text
| PDF

T
o elucidate the molecular mechanism of familial central diabetes insipidus (FDI), we sequenced the arginine vasopressin-neurophysin II (AVP-NPII) gene in 2 patients belonging to a pedigree that is consistent with an autosomal dominant mode of inheritance. 10 patients with idiopathic central diabetes insipidus (IDI) and 5 normals were also studied. The AVP-NPII gene, locating on chromosome 20, consists of three exons that encode putative signal peptide, AVP, NPII, and glycoprotein. Using polymerase chain reaction, fragments including the promoter region and all coding regions were amplified from genomic DNA and subjected to direct sequencing. Sequences of 10 patients with IDI were identical with those of normals, while in 2 patients with FDI, a single base substitution was detected in one of two alleles of the AVP-NPII gene, indicating they were heterozygotes for this mutation. It was a G----A transition at nucleotide position 1859 in the second exon, resulting in a substitution of Gly for Ser at amino acid position 57 in the NPII moiety. It was speculated that the mutated AVP-NPII precursor or the mutated NPII molecule, through their conformational changes, might be responsible for AVP deficiency.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(18)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
V. Nebes, J. Wall
|
Comprehensive Physiology
|
2011 |
Utility of AVP gene testing in familial neurohypophyseal diabetes insipidus
Sridhar Chitturi, Mark Harris, Michael J. Thomsett, Francis Bowling, Ivan McGown, David Cowley, Gary M. Leong, Jennifer Batch, Andrew M. Cotterill
|
Clinical Endocrinology
|
2008 |
Novel Insights into the Aetiology and Pathogenesis of Hypopituitarism
Mehul T. Dattani
|
Horm Res
|
2004 |
Novel Mutant Vasopressin-neurophysin II Gene Associated with Familial Neurohypophyseal Diabetes Insipidus
Masashi MIYAKOSHI, Kyuzi KAMOI, Takashi MURASE, Yoshihisa SUGIMURA, Yutaka OISO
|
Endocr J
|
2004 |
A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons
Theron A. Russell, Masafumi Ito, Mika Ito, Richard N. Yu, Fred A. Martinson, Jeffrey Weiss, J. Larry Jameson
|
J. Clin. Invest.
|
2003 |
Molecular genetics and animal models in autistic disorder
Christian Andres
|
Brain Research Bulletin
|
2002 |
Water-Losing and Water-Retaining States
Robert W. Schrier, Melissa A. Cadnapaphornchai, Fuminori Umenishi
|
Heart Disease
|
2001 |
Origin, differentiation and regulation of fetal and adult Leydig cells
René Habert, Hervé Lejeune, José M Saez
|
Molecular and Cellular Endocrinology
|
2001 |
Genetic models of vasopressin deficiency
Frederick D. Grant
|
Experimental Physiology
|
2000 |
Heterologous Expression of Human Vasopressin-Neurophysin Precursors in a Pituitary Cell Line: Defective Transport of a Mutant Protein from Patients with Familial Diabetes Insipidus
GISELA OLIAS, DIETMAR RICHTER, HARTWIG SCHMALE
|
DNA and Cell Biology
|
1996 |
|